Investment Q&A

Q: I'm looking for growth stocks from the Growth Portfolio that have been beaten up and are potentially poised to rebound soon and have the highest possible up side for my TFSA.

I your view currently , with the exception of ITC which I just purchased. Which other one or two would you consider right now.

Thanks

Q: I'm 47 and have a balanced portfolio. My 30 days has passed on CRH Medical capital loss - so I could buy it back. I currently hold SIS and GUD in healthcare - while holding CSH as real estate/healthcare. Healthcare represents 8% of my portfolio while real estate represents 3% with REITS such as CAR.UN CSH.UN HR.UN and small REI.UN. Should I relook at CRH or add another like SIA? COV is a little small for me, but looks interesting. I can wait until after October 25th to see how CRH reports.

Q: Hello

I have a position in CRH that is about flat from where I bought it. Do you think it is worth switching from CRH to COV?

Thanks
Amy

Q: Hello Peter,
My Frescii shares have tumbled 50% and am not sure if it is worth holding. What is your opinion? Do i hold or replace it with prometic or crh medical or for longer term knight (gud). With respect to Jean Coutu, would you expect the stock to go above 24.50 at a later point (higher offer) as my average cost is about that range or simply let the merger go through and I will get cash and some metro stock. Thank you.

Q: Do you think we are at or close to the bottom? Would buying now put me in a position to have a substantial gain in 2 years lets say? Thanks

Q: As an add on to my earlier CRH question. Can you also comment on the lack of growth from Q3 last year to this upcoming Q3 even though they had many acquisitions. Is this due to the decrease in cases caused by the Hurricanes? More importantly 20% drop in Ebitda, what does the cause of this appear to be?

Q: Can you comment on CRH's comments regarding their outlook for Q3. Seems to be some negative data around a decrease in cases and impacts from Hurricane Irma. They threw in an acquisition to cushion the impact. Down 3%. What are your thoughts around this news?

Q: 5i Team,

Thanks for your service.

My portfolio is made up of your balanced equity portfolio + several growth portfolio companies, some large cap US companies & some equity portfolio companies. Very balanced with a hedge towards growth.

I have big winners all over the place, thank you!!!!

I am however down big (approx. 50% each) on 3 small cap names: AT, CRH & ITC.

They are now about 0.5% weightings.. fairly insignificant to my portfolio and I am wrestling with whether I top them up... leave them alone as is... sell and consolidate it into other names in my portfolio (ie. CLS, PKI & CAE comes to mind right now)... etc.

I have no tax benefit to sell as they are all in registered / TFSA accounts.

My question is how confident are you in these names? For a riskier investor, would you be ok with top ups to 1% weightings today? Should I just let them sit and maybe top up during tax loss season in a month or two? Or just sell?

Thank you for your guidance.

Q: Hi,

I have about 30% of my original modest investment in CRH left. In light of its recent performance I am tempted to
add enough to make CRH worth what my original investment was. Or should I just punt CRH and put the proceeds into my 2018 withdrawals ?

Thanks.

Q: I'm looking to add a healthcare stock. I sold CRH to lock in the loss and have watched it climb daily while I cannot buy it due to the 30 day CRA loss rule. I have have another 3 weeks before I could buy it. Should I look at other stocks in this sector that are better or wait and buy CRH? I have an 8% weighting in healthcare.

Q: Hi 5i, would you recommend buy crh at cuurent price ? Thanks

Q: Hello Peter & Ryan and Team,

Can you comment on the recent majority purchase from CRH. The market liked it and I do like how it was done with credit and cash on hand instead of stock. Your expert opinion please.

Wes

Q: Do you think this is near a bottom?
Would you be a buyer at these levels?
Thanks

Q: Morning guys,

Crh is dipping again and presently at the 2.80 level. I am getting punished resulting in a 60 percent loss. Are you guys now at the breaking point and removing this company from your growth portfolio. I am willing to wait it out , are you folks.?

Thanks.

Q: Good morning,

With sells as it was going up, I am still about breakeven on CRH but it has dropped to 1% of my portfolio. I have lost confidence such that I won't put more in. I am, however, looking for additional healthcare exposure. Right now I am also holding JNJ (3%) Danaher (DHR, 4%) which is mostly medical/dental since the spin-off of Fortive. I have been thinking of exiting JNJ due to the price that they paid for their latest acquisition. It seems a little inconsistent with their historically very conservative nature.

Would you think that adding a 2.5-3% SIS or GUD is a better approach, or should I keep CRH given its longer term potential? I prefer to not watch my investments every day and have a diversified portfolio across market cap and Canada/US with a lot of multinational companies (like CCL in Canada and UL in the US, for instance).

Do you have any perspective on the JNJ acquisition? If so, please feel free to deduct two questions.

Thanks!

Derek

Q: On Nov 26, 2016 I asked if CRH has risen too quickly and was likely to decline materially. You mentioned the fundamentals were strong and it was not like other prominent TSX collapses of recent years.

Now that the stock has collapsed rather predictably I ask why do you still think share price momentum is a good thing to chase.

Q: hi Peter, out of these which ones would you recommend for adding onto with new money to add onto the existing positions. which ones are ok to let go.
thanks

Q: with my book value of $5000+ for CRH do you think it is worth holding on or just take the loss and go forward. Thank you

Q: Morning Peter and team, In addition to the core 5i big-cap stable names, we own healthy positions in GUD, GPS, KXS, PHO, PTE, OTEX, TCN & TV and a 1/2 position in PLI, and have ~35% portfolio cash. What are the next 2 small caps you would add here ? Would you initiate a position in CRH ? Thanks, Paul

Q: For those deeply under water on CRH, still in the stock and looking for positives:

1) Look at the Cash Flow Statement (not the Income Statement):
- This business makes real cash... CF-Operation is $9.75M
- Deducting 'non-controlling interest of $2.2 still leaves $7.5M
- CF Financing noisy due to retirement of high interest Crown and replacing by Scotia 3.5% loan - but there is cash generated for acquisition, debt replayment, etc.


2) Mawer Management is not selling... they are buying (as of end July)!
- Guy wondered about Mawer on July 16. I also track them as they are the best Management firm. Like everyone, they will have their share of losers and this may be one (they are sure deep under water) - so no guarantee but they are buying, not selling:
- Q2 data from Morningstar, they bought 924K shares and owned 6.43%
- How about July when the CMS reimbursement rate occurred? They bought +24% more (they manage the 'BMO enterprise' fund)
- How about after Q2? That we don't know yet...


3) One Director bought shares (independent Director, not Management)
- Per canadianinsider, Tood Patrick bought 50,000 shares on Aug 9/10
- Still would like to see the CEO or other Management buy but this is a first sign.